Clinical trials
Recruiting Essential Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yi Yang | 2 |
| Beijing Anzhen Hospital | 1 |
| Istituto Auxologico Italiano | 1 |
| Lepu Medical Technology (Beijing) Co., Ltd. | 1 |
| Orchestra BioMed, Inc | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |
| Shanghai Minwei Biotechnology Co., Ltd | 1 |
| Shenzhen Pulsecare Medical Technology Co., Ltd. | 1 |
| Suzhou Alphamab Co., Ltd. | 1 |
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 11 |
| Hypertension | 4 |
| Isolated Systolic Hypertension | 1 |
| Vascular Remodeling | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.